Impact of octreotide counterion nature on the long-term stability and release kinetics from an in situ forming depot technology
10/08/2021
10/08/2021
Approaches for Systemic Delivery of Dystrophin Antisense Peptide Nucleic Acid in the mdx Mouse Model
04/06/2021
04/06/2021
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables
22/04/2021
22/04/2021
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Amphiphilic Copolymers for Long-Acting Injectables: Synthesis, Non-Acylating Performance and In Vivo Degradation
06/03/2021
06/03/2021
Expert Review Report: Medical Safety of Ivermectin
03/03/2021
03/03/2021
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation
20/09/2020
20/09/2020
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle
18/05/2020
18/05/2020
BEPO®: Bioresorbable diblock mPEG-PDLLA and triblock PDLLA-PEG- PDLLA based in situ forming depots with flexible drug delivery kinetics modulation
